FEM-Based Electromagnetic Wave Simulator Running on Some Platforms by Use of Java and a Commercial Tool
スポンサーリンク
概要
- 論文の詳細を見る
- 2003-11-01
著者
-
HAYASHI Yoshio
Department of Medicinal Chemistry, Center for Frontier Research in Medicinal Science and 21st Centur
-
KOSHIBA Masanori
Division of Electronics and Information Engineering, Hokkaido University
-
Koshiba Masanori
Division Of Electronics And Information Engineering Hokkaido University
-
HIRAYAMA Koichi
Department of Electrical and Electronic Engineering, Kitami Institute of Technology
-
KUNIEDA Naoto
Department of Electrical and Electronic Engineering, Kitami Institute of Technology
-
Kunieda Naoto
Department Of Electrical And Electronic Engineering Kitami Institute Of Technology
-
Hayashi Yoshio
Department Of Pathology Tokushima University School Of Dentistry
-
Koshiba Masanori
Division Of Electronics And Information Engineering Faculty Of Engineering Hokkaido University
-
Hayashi Yoshio
Department Of Electrical And Electronic Engineering Kitami Institute Of Technology
-
Hirayama K
Department Of Electrical And Electronic Engineering Kitami Institute Of Technology
-
Hirayama Koichi
Department Of Electrical And Electronic Engineering Kitami Institute Of Technology
-
Hayashi Yoshio
Department Of Chemistry Faculty Of Science Kanazawa University
関連論文
- ミクリッツ病3例の検討
- 318 小児シェーグレン症候群における抗α-フォドリン抗体のエピトープ解析(膠原病と類縁疾患(1), 第55回日本アレルギー学会秋季学術大会)
- 319 経過中に抗α-fodrin抗体が陽性化した小児多発性硬化症(MS)の1例(膠原病と類縁疾患(1), 第55回日本アレルギー学会秋季学術大会)
- Development of New Photoresponsive Paclitaxel Prodrug
- Phototaxel : Development of First Photoresponsive Prodrug of Paclitaxel via Modification of Phenylisoserine Moiety
- "Click Peptide" : the "O-Acyl Isopeptide Method" for Peptide Synthesis and Development of Chemical Biology-Oriented Aβ Analogues
- "Click Peptide" Based on the "O-Acyl Isopeptide Method" : Development of Chemical Biology-Oriented Alzheimer's Disease-Related Aβ1-42 Analogues
- 頬粘膜部に発生した乳頭状嚢胞型腺房細胞癌の1例
- Design and Synthesis of Dipeptide-type HIV-1 Protease Inhibitors with High Antiviral Activity
- Controlled Drug Release : Design and Application of New Water-soluble Prodrugs